NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
No screener snapshot for this ticker.
Tekla Life Sciences Investors is a closed-ended equity mutual fund. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector.
No reported earnings periods on file.
No annual data.
No quarterly data.
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | Mahai Chris LaVictoire | Buy | 527 | $19.92 | $10,497.84 | filing |
| 2025-12-16 | Pittard Christian | Buy | 7,923 | $16.88 | $133,754.50 | filing |
| 2025-09-22 | Saba Capital Management, L.P. | Sale | 41,623 | $14.14 | $588,549.22 | filing |
| 2025-09-19 | Saba Capital Management, L.P. | Sale | 6,989 | $14.10 | $98,544.90 | filing |
| 2025-09-18 | Saba Capital Management, L.P. | Sale | 40,208 | $14.07 | $565,726.56 | filing |
| 2025-09-17 | Saba Capital Management, L.P. | Sale | 24,328 | $13.99 | $340,348.72 | filing |
| 2025-09-16 | Saba Capital Management, L.P. | Sale | 2,026 | $13.99 | $28,343.74 | filing |
| 2025-09-15 | Saba Capital Management, L.P. | Sale | 700 | $14.13 | $9,891.00 | filing |
| 2025-09-11 | Saba Capital Management, L.P. | Sale | 15,116 | $14.28 | $215,856.48 | filing |
| 2025-09-02 | Saba Capital Management, L.P. | Sale | 14,083 | $14.04 | $197,725.32 | filing |
| 2025-08-29 | Saba Capital Management, L.P. | Sale | 23,723 | $13.89 | $329,512.47 | filing |
| 2025-08-26 | Saba Capital Management, L.P. | Sale | 400 | $13.83 | $5,532.00 | filing |
| 2025-08-21 | Saba Capital Management, L.P. | Sale | 10,710 | $14.07 | $150,689.70 | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.